Erlotinib - PDFSEARCH.IO - Document Search Engine

Erlotinib
Results: 189

#	Item
61	Young Professionals is Our Future: EPMA-YPS Promotion Marzia Del Re, Pharm.D., Ph.D. University of Pisa Representative of the EPMA-YPS in Italy Add to Reading List Source URL: epmanet.eu Language: English - Date: 2013-09-26 11:05:08 KRAS Ras subfamily Cancer Breast cancer Erlotinib Medicine Chemistry Organic chemistry
62	Mechanism of Action Studies of NOV-002; a Novel Glutathione Disulfide Anti-cancer Drug Add to Reading List Source URL: cellectar.com Language: English - Date: 2014-02-10 13:10:22 Carcinogenesis Radiation oncology Prostate cancer AKT Radiation therapy Erlotinib Cancer stem cell Breast cancer Cell culture Medicine Biology Ribbon symbolism
63	Differential protein signatures in erlotinib-sensitive and resistant lung cancer cell lines in vitro and in vivo 1Deb 1Ying Add to Reading List Source URL: www.somalogic.com Language: English - Date: 2014-06-25 17:02:13 Proteins Erlotinib Cyclin-dependent kinase 2 Cyclin CDKN1B Epidermal growth factor receptor Tyrosine kinase Proteomics Protein kinase inhibitor Biology Cell biology Cell cycle
64	AstraZeneca submission to the Post-Market Review of Authority Required PBS listings AstraZeneca welcomes the opportunity to contribute to the Post-Market Review of Authority Required Pharmaceutical Benefits Schedule (PBS Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-04 00:10:33 Quinazolines Organofluorides Amines Organochlorides Pharmaceutical Benefits Scheme Protein kinase inhibitor Quality use of medicines Gefitinib Erlotinib Chemistry Organic chemistry AstraZeneca
65	1293 Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:25 Quinazolines Tyrosine kinase receptors Organofluorides Amines Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Afatinib Chemistry Organic chemistry Medicine
66	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
67	1293 Final Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV non-sma Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:26 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Afatinib Chemistry Organic chemistry Medicine
68	Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for a Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
69	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Sponsor/Applicant/s: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
70	MSAC Application 1173: Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) testing for eligibility for erlotinib treatment as a first line therapy in patients Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Lung cancer Amines Quinazolines Organofluorides Alkynes Gefitinib Erlotinib Non-small-cell lung carcinoma Epidermal growth factor receptor Medicine Chemistry Oncology

UPDATE